Thus, despite the other fucosylated proteins identified in melanoma cells (Extended Data Fig. 3), these data confirm that the N48 glycosylation–fucosylation of HLA-DRB1 is a key regulator of anti-melanoma immunity and tumor suppression. The gene discussed is HLA-DRB1; the disease is neoplasm.